Stay updated on Pembrolizumab for Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2. The study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T18:59:48.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH’s website terminology transition, and the site revision label changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T19:39:21.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:56:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page, replacing the expected study content with an error screen.
    Difference
    23%
    Check dated 2026-09-22T22:08:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page's revision history, replacing the previous Revision: v3.6.6. This indicates a new release of the page content or UI since the last update.
    Difference
    0.0%
    Check dated 2026-09-15T20:55:00.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.6, replacing v3.6.5, indicating a small page update. This reflects a minor update to the page rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-09-01T18:40:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Head and Neck Cancer Clinical Trial page.